Kelly Marcom

527 total citations
6 papers, 196 citations indexed

About

Kelly Marcom is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Kelly Marcom has authored 6 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Kelly Marcom's work include HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Treatment and Pharmacology (2 papers). Kelly Marcom is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Treatment and Pharmacology (2 papers). Kelly Marcom collaborates with scholars based in United States and Netherlands. Kelly Marcom's co-authors include David S. Hsu, Chaitanya R. Acharya, Eric P. Winer, Anil Potti, Gloria Broadwater, Clifford A. Hudis, Carey K. Anders, Yixin Wang, Yi Zhang and Sayan Mukherjee and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Kelly Marcom

6 papers receiving 195 citations

Peers

Kelly Marcom
Jasmine Sukumar United States
Joe Dennis United Kingdom
Arun Nagarajan United States
Tom van den Bosch Netherlands
Andrea Stefek Germany
Piergiorgio Giannessi Italy
Tak Loon Khong United Kingdom
Nur Sabrina Sapari Singapore
Carlos J. Gallego United States
Belén Herráez Spain
Jasmine Sukumar United States
Kelly Marcom
Citations per year, relative to Kelly Marcom Kelly Marcom (= 1×) peers Jasmine Sukumar

Countries citing papers authored by Kelly Marcom

Since Specialization
Citations

This map shows the geographic impact of Kelly Marcom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Marcom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Marcom more than expected).

Fields of papers citing papers by Kelly Marcom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Marcom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Marcom. The network helps show where Kelly Marcom may publish in the future.

Co-authorship network of co-authors of Kelly Marcom

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Marcom. A scholar is included among the top collaborators of Kelly Marcom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Marcom. Kelly Marcom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Tolaney, SM, Deborah Dillon, Kit Fuhrman, et al.. (2018). Abstract PD3-01: Immune profile of small HER2+ tumors in the APT trial. Cancer Research. 78(4_Supplement). PD3–1. 1 indexed citations
2.
Dang, Chau T., Hao Guo, Julie Najita, et al.. (2015). Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA Oncology. 2(1). 29–29. 69 indexed citations
3.
Dang, Chau T., Sara M. Tolaney, Julie Najita, et al.. (2011). P2-18-02: Cardiac Outcomes of Patients on Adjuvant Weekly Paclitaxel (T) and Trastuzumab (H) for Node Negative, HER2 Positive Breast Cancer (BCA).. Cancer Research. 71(24_Supplement). P2–18. 1 indexed citations
4.
Anders, Carey K., Chaitanya R. Acharya, David S. Hsu, et al.. (2008). Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors. PLoS ONE. 3(1). e1373–e1373. 74 indexed citations
5.
Polite, Blasé N., Constance Cirrincione, Gini F. Fleming, et al.. (2008). Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840—Cancer and Leukemia Group B. Journal of Clinical Oncology. 26(16). 2659–2665. 27 indexed citations
6.
Dietze, Eric C., Kelly Marcom, Steven Collins, et al.. (2002). Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microscopy Research and Technique. 59(1). 23–40. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasmine Sukumar Breakdown of academic impact, for papers by Joe Dennis Breakdown of academic impact, for papers by Arun Nagarajan Breakdown of academic impact, for papers by Tom van den Bosch Breakdown of academic impact, for papers by Andrea Stefek Breakdown of academic impact, for papers by Piergiorgio Giannessi Breakdown of academic impact, for papers by Tak Loon Khong Breakdown of academic impact, for papers by Nur Sabrina Sapari Breakdown of academic impact, for papers by Carlos J. Gallego Breakdown of academic impact, for papers by Belén Herráez
Rankless by CCL
2026